Page last updated: 2024-08-24

ziprasidone and Diabetes Mellitus, Type 2

ziprasidone has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaushik, S; Khan, A; Lindenmayer, JP; Parakadavil, M; Smith, RC; Tedeschi, F; Yusim, A	1
McNeely, MJ; Yang, SH	1
Alamy, SS; Jarskog, LF; Lieberman, JA; Sheitman, BB; Spivak, B	1
Citrome, L; Volavka, J	1
Perlis, RH	1

Reviews

2 review(s) available for ziprasidone and Diabetes Mellitus, Type 2

Article	Year
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. Postgraduate medicine, 2004, Volume: 116, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain	2004
Treatment of bipolar disorder: the evolving role of atypical antipsychotics. The American journal of managed care, 2007, Volume: 13, Issue:7 Suppl Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain	2007

Article

Year

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.

Postgraduate medicine, 2004, Volume: 116, Issue:4

Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain

2004

Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

The American journal of managed care, 2007, Volume: 13, Issue:7 Suppl

Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain

2007

Other Studies

3 other study(ies) available for ziprasidone and Diabetes Mellitus, Type 2

Article	Year
Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia. Clinical schizophrenia & related psychoses, 2012, Volume: 5, Issue:4 Topics: Analysis of Variance; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Piperazines; Polypharmacy; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome	2012
Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone. The American journal of psychiatry, 2002, Volume: 159, Issue:8 Topics: Antipsychotic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Fever; Humans; Hyperglycemia; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Pancreatitis; Piperazines; Psychotic Disorders; Rhabdomyolysis; Thiazoles	2002
Ziprasidone alternative for olanzapine-induced hyperglycemia. The American journal of psychiatry, 2002, Volume: 159, Issue:9 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Male; Olanzapine; Piperazines; Pirenzepine; Schizophrenia, Paranoid; Thiazoles; Treatment Outcome	2002